Stock Market

Cupid’s journey, in numbers

A small Nashik maker that became the world’s go-to supplier for a niche the world cannot do without, Cupid’s journey in numbers.

By · Markets professional · · 1 min read · 116 words

Cupid’s journey, a Nashik maker that became a global public-health niche leader. Cupid’s journey, a Nashik maker that became a global public-health niche leader.
Cupid’s journey, in numbers.
Listen to this article
0:00/--:--
Key takeaways
  • Founded in 1993 to manufacture condoms for India’s public-health market, then certified for global supply.
  • WHO prequalification (from 2003) created a moat very few competitors could cross.
  • It became the world’s only listed pure-play female-condom maker in 2015, supplying UN agencies.
  • By FY25 it ran on roughly ₹150 crore revenue, 20%+ margins and a debt-free balance sheet, while diversifying into medical products.
  • 1993 Omprakash Garg founds Cupid in Nashik on the bet that India lacks a domestic mass manufacturer of condoms for the public-health market.
  • 1995 It builds a compliant facility for male and female condoms and becomes a regular supplier to the Government of India’s family-welfare programmes.
  • 2003 It begins the World Health Organisation prequalification process, a multi-year certification that creates a moat few rivals can cross.
  • 2010 It becomes a regular supplier to United Nations agencies including UNFPA, and its female-condom franchise scales globally.
  • 2015 Cupid becomes the world’s only listed pure-play female-condom manufacturer.
  • 2018 It begins exporting at scale to Africa, Latin America, the Caribbean and Southeast Asia.
  • 2022 It diversifies strategically into hospital and medical-product manufacturing.
  • 2024 A promoter restructuring and change-of-control transition begins, alongside new capacity expansion.
  • FY25 Revenue runs around ₹150 crore with operating margins above 20% and a debt-free balance sheet.
  • 2025 Hospital products and lubricant gels begin to scale, while order books from UNFPA and health ministries stay at multi-year highs.
  • 2026 The female-condom franchise gains traction in private retail in Africa, and diversification beyond condoms reduces single-product concentration.

Cupid is proof that some of the most durable compounders are the smallest companies that own a global niche outright. A modest Nashik manufacturer became the world’s go-to supplier for products public-health systems cannot do without, debt-free, dividend-paying, and backed by repeat institutional customers. Here is the journey, year by year.

The pattern is the point

Cupid is a small Nashik manufacturer that became the world’s default supplier for a niche the world cannot do without, built on a debt-free balance sheet, a consistent dividend and repeat institutional customers. The smallest companies that genuinely own a global niche are often the most durable compounders, precisely because the moat is regulatory and the customers keep coming back.

Frequently asked questions

What does Cupid do?

It manufactures male and female condoms and related products for public-health programmes and UN agencies, and is diversifying into hospital and medical products.

What is Cupid’s moat?

WHO prequalification and long-standing approvals to supply UN agencies and government health programmes are difficult and slow for competitors to obtain, protecting its niche.

Why is it considered durable?

A debt-free balance sheet, 20%+ margins, consistent dividends and repeat institutional customers give it resilience unusual for a company its size.

Is this article financial advice?

No. It is a company history for general interest, not investment advice or a recommendation about Cupid or any security. This blog is for information and general interest only. It is not investment advice or a recommendation to buy or sell any company or security. Figures and dates are drawn from public sources. COVER, DARK MODE · use this version on the dark site theme

Related analysis

Stock MarketAcutaas Chemicals’ journey, in numbersA quiet specialty-chemicals franchise built for fifteen years, then a pivot to battery materials. Acutaas Chemicals’ journey in numbers. Stock MarketMTAR Technologies’ journey, in numbersNot in any single trend, sitting in the picks-and-shovels layer of five strategic cycles at once. MTAR Technologies’ journey in numbers. Stock MarketAnand Rathi Wealth’s journey, in numbersIt needed a country with rising household wealth and shrinking love of fixed income, Anand Rathi Wealth’s journey in numbers.
X / Twitter LinkedIn YouTube